Component
Monascin
Context-specific entity; species, compartment and exposure are stated on each claim.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Adding monascin increased hepatic AMPK phosphorylation in high-fat-diet-fed mice.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- C57BL/6 mouse liver; exposure dose not available in the accessed abstract.
- limitations
- Phosphorylation is not proof of direct AMPK binding or a demonstrated effect of every red yeast rice product.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- A pigment changed an energy-regulation signal in mice.
- primary_references
- [24275089] Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24275089/ · DOI 10.1016/j.fct.2013.11.015
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 204–210
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · C57BL/6 mouse liver; exposure dose not available in the accessed abstract. · source_derived_draft · unverified_draft
## red-yeast-rice-monascin-ampk A pigment changed an energy-regulation signal in mice. Adding monascin increased hepatic AMPK phosphorylation in high-fat-diet-fed mice. Model: C57BL/6 mouse liver; exposure dose not available in the accessed abstract. Limitations: Phosphorylation is not proof of direct AMPK binding or a demonstrated effect of every red yeast rice product. Evidence access: Primary abstract [24275089] Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24275089/ · DOI 10.1016/j.fct.2013.11.015
Complete structured claim and evidenceDocking proposed monascin binding outside the catalytic center of the alpha-glucosidase model.
Experimental context and source evidence
- evidence_access
- Primary full text PMC11120408
- experimental_model
- Computational analysis accompanying enzyme kinetics.
- limitations
- No ligand-bound crystal structure or direct human-enzyme result follows.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The proposed contact site remains a model.
- primary_references
- [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 300–306
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Computational analysis accompanying enzyme kinetics. · source_derived_draft · unverified_draft
## red-yeast-rice-monascin-docking The proposed contact site remains a model. Docking proposed monascin binding outside the catalytic center of the alpha-glucosidase model. Model: Computational analysis accompanying enzyme kinetics. Limitations: No ligand-bound crystal structure or direct human-enzyme result follows. Evidence access: Primary full text PMC11120408 [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Complete structured claim and evidenceMonascin inhibited yeast alpha-glucosidase with an IC50 of 302.6 micromolar and mixed-type kinetics.
Experimental context and source evidence
- evidence_access
- Primary full text PMC11120408
- experimental_model
- Saccharomyces cerevisiae enzyme, pNPG substrate, pH 6.8; one-hour preincubation and 30-minute reaction.
- limitations
- Yeast enzyme, not human intestinal maltase-glucoamylase or sucrase-isomaltase; potency is not clinical glucose lowering.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- The isolated pigment inhibited a carbohydrate-cleaving enzyme preparation.
- primary_references
- [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 292–298
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Saccharomyces cerevisiae enzyme, pNPG substrate, pH 6.8; one-hour preincubation and 30-minute reaction. · source_derived_draft · unverified_draft
## red-yeast-rice-monascin-glucosidase The isolated pigment inhibited a carbohydrate-cleaving enzyme preparation. Monascin inhibited yeast alpha-glucosidase with an IC50 of 302.6 micromolar and mixed-type kinetics. Model: Saccharomyces cerevisiae enzyme, pNPG substrate, pH 6.8; one-hour preincubation and 30-minute reaction. Limitations: Yeast enzyme, not human intestinal maltase-glucoamylase or sucrase-isomaltase; potency is not clinical glucose lowering. Evidence access: Primary full text PMC11120408 [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Complete structured claim and evidenceMonascin increased hepatic PPAR-alpha expression and promoted a fatty-acid-oxidation program in the mouse study.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- High-fat-diet C57BL/6 mice; related mouse FL83B hepatocyte experiments also reported.
- limitations
- The paper describes agonist activity; the accessed abstract does not resolve direct receptor affinity or establish a human clinical effect.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- A transcriptional program provides a distinct route from statin inhibition.
- primary_references
- [24275089] Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24275089/ · DOI 10.1016/j.fct.2013.11.015
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 212–218
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · High-fat-diet C57BL/6 mice; related mouse FL83B hepatocyte experiments also reported. · source_derived_draft · unverified_draft
## red-yeast-rice-monascin-ppara A transcriptional program provides a distinct route from statin inhibition. Monascin increased hepatic PPAR-alpha expression and promoted a fatty-acid-oxidation program in the mouse study. Model: High-fat-diet C57BL/6 mice; related mouse FL83B hepatocyte experiments also reported. Limitations: The paper describes agonist activity; the accessed abstract does not resolve direct receptor affinity or establish a human clinical effect. Evidence access: Primary abstract [24275089] Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24275089/ · DOI 10.1016/j.fct.2013.11.015
Complete structured claim and evidence
Where it participates (unsigned role)
The pigment-rich fermentation product at 0.2 mg/mL reduced fluorescent AGE formation by 87.1% in the BSA–fructose assay.
Experimental context and source evidence
- evidence_access
- Primary full text PMC11120408
- experimental_model
- Cell-free bovine albumin and fructose experiment.
- limitations
- Not purified ankaflavin alone, and fluorescence inhibition is not a clinical diabetes endpoint.
- nutrient_topic
- Red yeast rice collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Red yeast rice
- plain_language
- A particular mixture changed a glycation readout.
- primary_references
- [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Red yeast rice: constituents, mevalonate, CoQ and product-specific interactions (2026-09-20) · lines 308–314
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free bovine albumin and fructose experiment. · source_derived_draft · unverified_draft
## red-yeast-rice-mixture-glycation A particular mixture changed a glycation readout. The pigment-rich fermentation product at 0.2 mg/mL reduced fluorescent AGE formation by 87.1% in the BSA–fructose assay. Model: Cell-free bovine albumin and fructose experiment. Limitations: Not purified ankaflavin alone, and fluorescence inhibition is not a clinical diabetes endpoint. Evidence access: Primary full text PMC11120408 [38790873] Revealing the Hypoglycemic Effect of Red Yeast Rice: Perspectives from the Inhibition of α-Glucosidase and the Anti-Glycation Capability by Ankaflavin and Monascin. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38790873/ · DOI 10.3390/foods13101573
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.